Of patients manifested MSH6 deficiency, 2 cases (2/9, 22.2%) developed endometrial cancer, one case (1/9, 11.1%) developed gastric cancer in LS group; 2 cases (1/6, 33.3%) developed gastric cancer. The gene discussed is MSH6; the disease is gastric cancer.